CS-2660 是一种耐受性好的，有口服活性的、高效的、选择性的VEGFR-2抑制剂 (IC50:40 nM)，还能抑制 Ret (IC50:180 nM) 和 Kit (IC50:500 nM)。

CS-2660, a highly selective, orally available, well tolerated VEGFR2 inhibitor with IC50 of 40 nM, inhibits closely related tyrosine kinases such as Ret and Kit with IC50 of 180 nM and 500 nM.

951151-97-6

C15H17ClN6O3

364.79

CS-2660

DMSO:30 mg/ml (82.24 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years